BioClad seals multi-million-pound contracts

The BioClad team celebrate their award success.

BioClad seals multi-million-pound contracts

The specialist manufacturer, supplier and installer of hygienic cladding technology has clinched a trio of high-profile contracts worth over £3m.

The wave of new business comes hot on the heels of the firm scooping a Queen’s Award for Enterprise.

Hinkley Point C nuclear power station commissioned the Harrogate-based antimicrobial specialist in a £1.75m contract to install over 45,000 sqm of wall linings, the biggest installation of its kind, in its staff accommodation villages. 

The second contract came from global chemical manufacturer BASF naming BioClad as its exclusive partner and offering BioClad’s antimicrobial wall cladding and associated products to pharmaceutical, healthcare and leisure clients across the Middle East.

BioClad is also delivering a pan-continental rollout of upgrades to hygienic spaces in every Five Guys burger brand outlet in France and Spain.

Continuing on its export success in principal markets spanning Australia, Canada, Europe, India, Saudi Arabia, UAE and Mexico, BioClad has now opened an Australian subsidiary in Perth.

Global sales account for 25% of its £10 million turnover which has increased by 15% over the last year.

BioClad is the first company in its sector to achieve a Queen’s Award in International Trade.

Its export sales director, Andy Newbould, was presented with a glass bowl and scroll by Her Majesty’s representative for North Yorkshire, York and Teeside, the Lord Lieutenant of North Yorkshire, Mr Barry Dodd CBE, at a ceremony at the company’s Cardale Park offices.

BioClad founder and director, Lindsay McKenzie, said: “Our reputation as a global leader in revolutionising antimicrobial hygienic spaces in key sectors including healthcare, pharmaceutical and education has reached new heights following our Queen’s Award.

“The accolade has acted as a magnet to secure prestigious new commissions and further boost our team by 25%.

“With the global flooring and wall cladding market estimated to be worth 200 billion dollars by 2020, we are uniquely placed to fulfil a further acceleration in demand for our products and services.”

Mr Dodd commented: “BioClad’s powerful achievements are truly inspiring and reinforce the clout, prestige and benefits of striving for a Queen’s Award.

“We wish Lindsay and Andy and the team continued success on their vibrant export journey.”      

BioClad is a world leader when it comes to revolutionising antimicrobial hygienic spaces in healthcare, pharmaceutical, education, retail, restaurant and leisure sectors.

Its products have been specified in large-scale projects including a £63 million Spire Healthcare hospital, a new 80-bedroom healthcare unit at West London Mental Health Centre, an £8.1m expansion of a neuroscience hospital at the Walton Centre and the installation of 10 all-new antimicrobial BioPod units at Harrogate Hospital Accident and Emergency department.

The firm’s products are now in high demand across the globe with international trade expanding rapidly in India, Saudi Arabia, Canada, Europe, Australia, New Zealand, Pakistan, United Arab Emirates and Egypt.